share_log

Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $225

Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $225

Keybanc維持對重症監護病房醫療的增持,將目標股價下調至225美元
Benzinga Real-time News ·  2022/08/09 04:34

Keybanc analyst Matthew Mishan maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $230 to $225.

Keybanc分析師馬修·米山維持ICU Medical(納斯達克股票代碼:ICUI)增持 “增持”,並將目標股價從230美元下調至225美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論